These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33982243)

  • 41. Association of systemic inflammatory indices with anthropometric measures, metabolic factors, and liver function in non-alcoholic fatty liver disease.
    Arefhosseini S; Aghajani T; Tutunchi H; Ebrahimi-Mameghani M
    Sci Rep; 2024 Jun; 14(1):12829. PubMed ID: 38834647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between CT Abdominal Anthropometric Measurements and Liver Density in Individuals with Non-Alcoholic Fatty Liver Disease.
    Cucoranu DC; Pop M; Niculescu R; Vunvulea V; Kosovski IB; Togănel RO; Russu E; Mureșan AV; Licu RA; Bacârea A
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984501
    [No Abstract]   [Full Text] [Related]  

  • 43. Associations of serum uric acid levels and anthropometric parameters with non-alcoholic fatty liver disease in healthy individuals: innovative insights from a cross-sectional study.
    Aydin A; Goktas Aydin S
    Curr Med Res Opin; 2024 Feb; 40(2):209-215. PubMed ID: 38111962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrotic NASH in Individuals with Obesity: a Cross-sectional Analysis of the Prevalence of this Significant Milestone of Disease Progression and Accuracy of a Non-invasive Marker for its Screening.
    de Souza Echeverria L; Mounzer DLS; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2024 Feb; 34(2):389-395. PubMed ID: 38110785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
    Vongsuvanh R; George J; McLeod D; van der Poorten D
    J Hepatol; 2012 Aug; 57(2):392-8. PubMed ID: 22521350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HbA
    Masroor M; Haque Z
    J Clin Transl Hepatol; 2021 Feb; 9(1):15-21. PubMed ID: 33604251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan.
    Agarwal L; Aggarwal S; Shalimar ; Yadav R; Dattagupta S; Garg H; Agarwal S
    Obes Surg; 2021 Feb; 31(2):617-626. PubMed ID: 33052552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease.
    Eremić-Kojić N; Đerić M; Govorčin ML; Balać D; Kresoja M; Kojić-Damjanov S
    Hippokratia; 2018; 22(1):10-16. PubMed ID: 31213752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
    Niriella MA; Kasturiratna A; Beddage T; Ediriweera DS; De Silva ST; Perera KR; Subasinghe CE; Kodisinghe SK; Piyaratna TC; Rishikesawan V; Dassanayaka AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; Janaka de Silva H
    PLoS One; 2019; 14(10):e0224474. PubMed ID: 31661524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum Ferritin and NAFLD in Patients Undergoing Bariatric Surgery.
    Giacomazzi CB; Tovo CV; Moreira TR; Pase THS; Linhares AB; Coral GP; Rinaldi N; Pioner SR; De Carli LA; Fontes PRO
    Obes Surg; 2022 Aug; 32(8):2658-2663. PubMed ID: 35670949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Morbid obesity, non-alcoholic fatty liver disease, metabolic syndrome and bariatric surgery].
    Silvestre V; Ruano M; García-Lescún MC; Aguirregoicoa E; Criado L; Rodríguez A; Marco A; García-Blanch G
    Nutr Hosp; 2007; 22(5):602-6. PubMed ID: 17970546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonalcoholic fatty liver disease of two ethnic groups in Kuwait: comparison of prevalence and risk factors.
    Babusik P; Bilal M; Duris I
    Med Princ Pract; 2012; 21(1):56-62. PubMed ID: 22024606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
    Mohamed RZ; Jalaludin MY; Anuar Zaini A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neck circumference: a useful screening tool of cardiovascular risk in children.
    Androutsos O; Grammatikaki E; Moschonis G; Roma-Giannikou E; Chrousos GP; Manios Y; Kanaka-Gantenbein C
    Pediatr Obes; 2012 Jun; 7(3):187-95. PubMed ID: 22505226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Risk factors analysis of nonalcoholic fatty liver disease in Chinese men].
    Zheng RD; Zhuang QY; Chen JN; Chen J; Lu YH
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):62-5. PubMed ID: 23663766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between neck circumference and non-alcoholic fatty liver disease: cross-sectional analysis from ELSA-Brasil.
    Santos LLM; Diniz MFHS; Goulart AC; Barreto SM; Figueiredo RC
    Sao Paulo Med J; 2022; 140(2):213-221. PubMed ID: 35043830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The discriminative ability of waist circumference, body mass index and waist-to-hip ratio in identifying metabolic syndrome: Variations by age, sex and race.
    Cheong KC; Ghazali SM; Hock LK; Subenthiran S; Huey TC; Kuay LK; Mustapha FI; Yusoff AF; Mustafa AN
    Diabetes Metab Syndr; 2015; 9(2):74-8. PubMed ID: 25819369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Markers of adiposity in HIV/AIDS patients: Agreement between waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index.
    Dimala CA; Ngu RC; Kadia BM; Tianyi FL; Choukem SP
    PLoS One; 2018; 13(3):e0194653. PubMed ID: 29566089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of body mass index and waist-to-hip ratio as indicators of hypertension risk in an urban Argentine population: a hospital-based study.
    Feldstein CA; Akopian M; Olivieri AO; Kramer AP; Nasi M; Garrido D
    Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):310-5. PubMed ID: 16054556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a propensity matched cross-sectional comparison.
    Maldonado FHR; Mega PF; Germano CW; Dias LLC; Callejas GH; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Sao Paulo Med J; 2024; 142(1):e2022663. PubMed ID: 37311134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.